Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned
  2. Stransky, Laura A; Gao, Wenhua; Schmidt,Laura; Bi, Kevin; Ricketts, Christopher J; Ramesh, Vijyendra; James,Amy; Difilippantonio,Simone; Ileva,Lilia; Kalen,Joseph; Karim,Baktiar; Jeon, Albert; Morgan,Tamara; Warner,Andrew; Turan, Sevilay; Unite,Joanne; Tran,Bao; Choudhari,Sulbha; Zhao,Yongmei; Linn, Douglas E; Yun, Changhong; Dhandapani, Sripriya; Parab, Vaishali; Pinheiro, Elaine M; Morris,Nicole; He, Lixia; Vigeant, Sean M; Pignon, Jean-Christophe; Sticco-Ivins, Maura; Signoretti, Sabina; Van Allen, Eliezer M; Linehan, W Marston; Kaelin, William G
  3. Proceedings of the National Academy of Sciences of the United States of America. 2024, Oct 08; 121(41): e2408549121.
  1. 2.   Comprehensive characterization of Alu-mediated breakpoints in germline VHL gene deletions and rearrangements in patients from 71 VHL families
  2. Vocke, Cathy D.; Ricketts, Christopher J.; Schmidt,Laura; Ball, Mark W.; Middelton, Lindsay A.; Zbar, Berton; Linehan, W. Marston
  3. Human Mutation. 2021, Mar 06; 42(5): 520-529.
  1. 3.   Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors
  2. Tirosh, Amit; Mukherjee, Sanjit; Lack, Justin; Gara, Sudheer Kumar; Wang, Sophie; Quezado, Martha M; Keutgen, Xavier M; Wu, Xiaolin; Cam, Maggie; Kumar, Suresh; Patel, Dhaval; Nilubol, Naris; Tyagi, Monica Varun; Kebebew, Electron
  3. Cancer. 2019, Apr 15; 125(8): 1247-1257.
  1. 4.   Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer
  2. Cherkasova, E.; Malinzak, E.; Rao, S.; Takahashi, Y.; Senchenko, V. N.; Kudryavtseva, A. V.; Nickerson, M. L.; Merino, M.; Hong, J. A.; Schrump, D. S.; Srinivasan, R.; Linehan, W. M.; Tian, X.; Lerman, M. I.; Childs, R. W.
  3. Oncogene. 2011, Nov; 30(47): 4697-4706.
  1. 5.   Molecular Diagnosis and Therapy of Kidney Cancer
  2. Linehan, W. M.; Bratslavsky, G.; Pinto, P. A.; Schmidt, L. S.; Neckers, L.; Bottaro, D. P.; Srinivasan, R.
  3. Annual Review of Medicine. 2010, Feb; 61: 329-343.
  1. 6.   Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours
  2. Ivanova, A. V.; Vortmeyer, A.; Ivanov, S. V.; Nickerson, M. L.; Maher, E. R.; Lerman, M. I.
  3. Journal of Pathology. 2008 214(1): 46-57.
  1. 7.   Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
  2. Nickerson, M. L.; Jaeger, E.; Shi, Y.; Durocher, J. A.; Mahurkar, S.; Zaridze, D.; Matveev, V.; Janout, V.; Kollarova, H.; Bencko, V.; Navratilova, M.; Szeszenia-Dabrowska, N.; Mates, D.; Mukeria, A.; Holcatova, I.; Schmidt, L. S.; Toro, J. R.
  3. Clinical Cancer Research. 2008 14(15): 4726-4734.
  1. 8.   EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1
  2. Thomas, S. L.; Zhong, D. S.; Zhou, W.; Malik, S.; Liotta, D.; Snyder, J. P.; Hamel, E.; Giannakakou, P.
  3. Cell Cycle. 2008 7(15): 2409-2417.
  1. 9.   Expression of hypoxia-inducible factor 1 alpha, hypoxia-inducible factor 2 alpha, and von Hippel-Lindau protein in epitheLiaL ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1 alpha is an independent prognostic factor in ovarian carcinoma
  2. Osada, R.; Horiuchi, A.; Kikuchi, N.; Yoshida, J.; Hayashi, A.; Ota, M.; Katsuyama, Y.; Melilo, G.; Konishi, I.
  3. Human Pathology. 2007, Sep; 38(9): 1310-1320.
  1. 10.   Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13
  2. Ivanov, S. V.; Salnikow, K.; Ivanova, A. V.; Bai, L.; Lerman, M. I.
  3. Oncogene. 2007, Feb; 26(6): 802-812.
  1. 11.   Development of a cell-based reporter assay for screening of inhibitors of hypoxia-inducible factor 2-induced gene expression
  2. Woldemichael, G. M.; Vasselli, J. R.; Gardella, R. S.; McKee, T. C.; Linehan, W. M.; McMahon, J. B.
  3. Journal of Biomolecular Screening. 2006, Sep; 11(6): 678-687.
  1. 12.   Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis
  2. Hong, S. B.; Furihata, M.; Baba, M.; Zbar, B.; Schmidt, L. S.
  3. Laboratory Investigation. 2006, Jul; 86(7): 664-675.
  1. 13.   Topotecan blocks hypoxia-inducible factor-1 alpha, and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells
  2. Beppu, Y.; Nakamura, K.; Linehan, W. M.; Rapisarda, A.; Thiele, C. J.
  3. Cancer Research. 2005, JUN 1; 65(11): 4775-4781.
  1. 14.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 15.   Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location
  2. Maranchie, J. K.; Afonso, A.; Albert, P. S.; Kalyandrug, S.; Phillips, J. L.; Zhou, S.; Peterson, J.; Ghadimi, B. M.; Hurley, K.; Riss, J.; Vasselli, J. R.; Ried, T.; Zbar, B.; Choyke, P.; Walther, M. M.; Klausner, R. D.; Linehan, W. M.
  3. Human Mutation. 2004 23(1): 40-46.
  1. 16.   HIF-1 - An oxygen and metal responsive transcription factor
  2. Maxwell, P.; Salnikow, K.
  3. Cancer Biology & Therapy. 2004 3(1): 29-35.
  1. 17.   Searching for the hereditary causes of renal-cell carcinoma
  2. Pavlovich, C. P.; Schmidt, L. S.
  3. Nature Reviews Cancer. 2004 4(5): 381-393.
  1. 18.   The von Hippel-Lindau gene and protein in tumorigenesis and angiogenesis: A potential target for therapeutic designs
  2. Shiao, Y. H.
  3. Current Medicinal Chemistry. 2003 10(22): 2461-2470.
  1. 19.   Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation
  2. Haan, S.; Ferguson, P.; Sommer, U.; Hiremath, M.; McVicar, D. W.; Heinrich, P. C.; Johnston, J. A.; Cacalano, N. A.
  3. Journal of Biological Chemistry. 2003 278(34): 31972-31979.
  1. 20.   Studying cancer families to identify kidney cancer genes
  2. Zbar, B.; Klausner, R.; Linehan, W. M.
  3. Annual Review of Medicine-Selected Topics in the Clinical Sciences. 2003 54: 217-233.
  1. 21.   The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1
  2. Zhou, M. I.; Wang, H. M.; Ross, J. J.; Kuzmin, I.; Xu, C. G.; Cohen, H. T.
  3. Journal of Biological Chemistry. 2002 277(42): 39887-39898.
  1. 22.   Down-regulation of von Hippel-Lindau protein in N-nitroso compound-induced rat non-clear cell renal tumors
  2. Shiao, Y. H.; Ramakrishna, G.; Anderson, L. M.; Perantoni, A. O.; Rice, J. M.; Diwan, B. A.
  3. Cancer Letters. 2002 179(1): 33-38.
  1. 23.   The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis
  2. Dreijerink, K.; Braga, E.; Kuzmin, I.; Geil, L.; Duh, F. M.; Angeloni, D.; Zbar, B.; Lerman, M. I.; Stanbridge, E. J.; Minna, J. D.; Protopopov, A.; Li, J. F.; Kashuba, V.; Klein, G.; Zabarovsky, E. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(13): 7504-7509.
  1. 24.   Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein
  2. Ohh, M.; Takagi, Y.; Aso, T.; Stebbins, C. E.; Pavletich, N. P.; Zbar, B.; Conaway, R. C.; Conaway, J. W.; Kaelin, W. G.
  3. Journal of Clinical Investigation. 1999 104(11): 1583-1591.
  1. 25.   Analysis of aberrant methylation of the VHL gene by transgenes, monochromosome transfer, and cell fusion
  2. Kuzmin, I.; Geil, L.; Ge, H. Y.; Bengtsson, U.; Duh, F. M.; Stanbridge, E. J.; Lerman, M. I.
  3. Oncogene. 1999 18(41): 5672-5679.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel